Geary Richard S
EVP, Chief Development Officer
Geary Richard S has filed 6 SEC Form 4 filings (25 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Nov 7, 2025.
On the most recent filing, Geary Richard S is listed as EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC. Inside the rolling window, Geary Richard S reported no open-market purchases and 4 open-market sales totaling $9.5M in IONS. The largest disclosed transaction in the window is a sale of 89,249 IONS shares on Oct 31, 2025, worth $6.7M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Geary Richard S made?
Geary Richard S has filed 6 SEC Form 4 filings (25 transaction rows) across 1 company since 2025.
Which companies does Geary Richard S trade?
Geary Richard S has filed SEC Form 4 disclosures for 1 company, including IONS.
When was Geary Richard S's most recent SEC Form 4 filing?
Geary Richard S's most recent SEC Form 4 filing on Tracefour is dated Nov 7, 2025.
What is Geary Richard S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Geary Richard S is listed as EVP, Chief Development Officer.
What is Geary Richard S's total buy and sell value in the current window?
Inside the rolling retention window, Geary Richard S bought $0 and sold $9.5M based on SEC Form 4 filings.
What was Geary Richard S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 89,249 IONS shares on 2025-10-31, worth $6.7M, per SEC Form 4 filings.